Research Header Home Description

Created through the transformational philanthropy of Vickie and Jack Farber, the Vickie and Jack Farber Vision Research Center (VRC) at Wills Eye Hospital demonstrates a commitment to excellence in vision research aimed to impact sight preservation and eye health for generations to come.
Our mission is to leverage clinical and technological advances in health delivery systems, data analytics, artificial intelligence, genetics and precision medicine to drive breakthroughs through collaboration and innovation that empower lives by preserving vision through preventing, treating and curing eye disease. Learn more.

Slide 1
Image is not available
Gift from Wills Alumnus Supports Translational Research

Dr. Larry A. Donoso donates $5 million for establishment of an Endowed Chair for Research.

Image is not available
Glaucoma Visionary Joel Schuman Joins Wills Eye

World-renowned ophthalmologist Joel S. Schuman, MD, FACS will join Wills and the Vickie and Jack Farber Vision Research Center at Wills Eye.

Image is not available
Retina Research

Wills Eye Hospital and Penn Medicine Retina Research find improvement for night vision in adults with congenital blindness.

Featured Research

Graft Outcomes After Temporary Keratoprosthesis in Combined Penetrating Keratoplasty and Vitreoretinal Surgery

Yu J, Shalaby WS, Shiuey EJ, Rapuano CJ, Yonekawa Y, Hammersmith KM, Nagra PK, Syed ZA.

Corneal pathology can obstruct the visualization required for surgical management of coexisting posterior segment diseases, and use of a temporary keratoprosthesis (TKP) permits combined penetrating keratoplasty (PK) and vitreoretinal surgery. The researchers evaluated graft outcomes after TKP for combined PK and vitreoretinal surgery and analyzed risk factors for graft failure.

Publications List
A Comparison of Ocular Complications after 0.7-mg Dexamethasone Implant Versus 2 mg of Intravitreal Triamcinolone in Vitrectomized Eyes.
Alternative Techniques to Remove Retained Silicone Oil Droplets on IOLs.
Demographic and Socioeconomic Determinants of Penetrating Keratoplasty Outcomes.
Conjunctival Melanoma in 430 Cases: Comparative Analysis of the Impact of Orbital Invasion on Tumor Recurrence, Metastasis, and Death.
Initial Investigations of Intrinsically Disordered Regions in Inherited Retinal Diseases.
4-year Surgical Outcomes of Gonioscopy-assisted Transluminal Trabeculotomy (GATT) in Patients with Open-angle Glaucoma.
Slide 1
Support Our Research

Wills Eye research aims to leverage clinical and technological advances to drive breakthroughs in eye care. We are inventing the standards of tomorrow and training the next generation of clinician scientists. The only way we can fully realize our potential is with the support of our courageous patients and philanthropists, the people who have the foresight to understand these challenges. With your gift, you make an investment in leading-edge research that advances understanding and enhances life for generations to come.

Farber Testimonial

"Wills Eye is a great institution with incredibly talented people who are motivated, forward thinking and committed to advancing scientific knowledge. If you put those energies together with financial support to accelerate the rate of progress, you truly make a difference in patients' lives."

Jack Farber
Contact us